Cargando…

Optimal determination of Physician Global Assessment of lupus disease activity: a pilot study

Detalles Bibliográficos
Autor principal:	Aranow, Cynthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179569/ http://dx.doi.org/10.1186/ar4658

Ejemplares similares

Lymphoma risk in systemic lupus: effects of treatment versus disease activity
por: Clarke, AE, et al.
Publicado: (2012)

Lupus skin disease
por: Werth, Victoria P
Publicado: (2014)

Hopkins Lupus Cohort: assessment of treatment effects
por: Petri, M
Publicado: (2012)

Cancer risk factors in systemic lupus erythematosus: multivariate regression analysis in 16,409 patients
por: Bernatsky, Sasha, et al.
Publicado: (2014)

Methodological quality of studies of end-stage renal disease risks in lupus nephritis
por: Tektonidou, Maria, et al.
Publicado: (2014)

Epigenetics and lupus
por: Richardson, B
Publicado: (2012)

Serum chemokine levels predict flares of disease activity in two independent systemic lupus erythematosus cohorts
por: Bilgic, H, et al.
Publicado: (2012)

Development validation and reliability of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50
por: Touma, Z, et al.
Publicado: (2012)

Unmet needs in allergic rhinitis: international survey on management of allergic rhinitis by physician and patient: the optimal management (ISMAR 2 study)
por: Baena-Cagnani, Carlos E, et al.
Publicado: (2015)

DNA repair in lupus
por: Xu, Jiadi, et al.
Publicado: (2014)

Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial
por: Isenberg, David, et al.
Publicado: (2014)

Longitudinal analysis of mRNA transcripts and plasma proteins to define a biomarker associated with lupus disease activity
por: Olferiev, M, et al.
Publicado: (2012)

Platelet-derived microparticles serve as an important source of autoantigens and discriminate between levels of disease activity in systemic lupus erythematosus
por: Boilard, Eric, et al.
Publicado: (2014)

Elevated risk of chronic obstructive pulmonary disease in systemic lupus erythematosus: a population-based study
por: Avina-Zubieta, Antonio, et al.
Publicado: (2014)

Modeling the stochastic behavior of lupus
por: Roopenian, Derry C, et al.
Publicado: (2014)

Genetic-epigenetic interaction in lupus
por: Sawalha, AH
Publicado: (2012)

Protein microarray characterization of the autoantibody response in systemic lupus erythematosus and related diseases
por: Robinson, W, et al.
Publicado: (2001)

Preliminary population-based incidence and prevalence estimates of systemic lupus erythematosus: the California Lupus Surveillance Project
por: Dall'Era, Maria C, et al.
Publicado: (2014)

Comparative analysis of anti-histone and anti-chromatin antibody specificity in lupus erythematosus cell-positive and -negative sera and their relation to disease activity
por: Schett, G, et al.
Publicado: (2001)

Blimp-1 and systemic lupus erythematosus
por: Diamond, Betty, et al.
Publicado: (2014)

Protective natural autoantibodies and lupus pathogenesis
por: Silverman, Gregg J
Publicado: (2014)

Molecular characterization of proliferative lupus nephritis
por: Parikh, Samir V, et al.
Publicado: (2014)

Lung cancer in systemic lupus erythematosus
por: Kale, M, et al.
Publicado: (2012)

Microparticles as autoantigens in human and murine lupus
por: Ullal, A, et al.
Publicado: (2012)

Vasculitis and Systemic Lupus Erythematous (SLE)
por: Cortis, Elisabetta, et al.
Publicado: (2015)

Smoking and secondhand smoke among patients with systemic lupus erythematosus and controls: associations with disease and disease damage
por: Minkin, Samantha J, et al.
Publicado: (2014)

B-cell receptor signaling studies in patients with lupus: preliminary results
por: Faludi, M, et al.
Publicado: (2012)

Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus
por: Lin, Pin, et al.
Publicado: (2014)

Racial discrimination and disease damage among African American women with systemic lupus erythematosus
por: Chae, David H, et al.
Publicado: (2014)

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment
por: Kirou, Kyriakos A., et al.
Publicado: (2022)

Sociodemographics and epidemiology of serious infections requiring hospitalization among adults with systemic lupus erythematosus and lupus nephritis, 2000 to 2006
por: Feldman, Candace H, et al.
Publicado: (2014)

Rhinitis, sinusitis and ocular disease – 2089. Evaluating the quality and contents in paranasal sinusitis-related information on the web-sites in western physicians and eastern physicians
por: Kim, Yong-Dae, et al.
Publicado: (2013)

Unmet needs in allergic rhinitis: international survey on management of allergic rhinitis by physician and patient. The physicians' view (ISMAR 2 study)
por: Baena-Cagnani, Carlos E, et al.
Publicado: (2015)

Moving lupus epidemiology forward: returning to the basics
por: Simard, Julia F
Publicado: (2014)

Is prevention of systemic lupus erythematosus a goal?
por: Olsen, Nancy J, et al.
Publicado: (2014)

'Lupus headache': results from a prospective, international, inception cohort study
por: Hanly, John G
Publicado: (2014)

Time to lupus nephritis: impact of gender and ethnicity
por: Seligman, VA, et al.
Publicado: (2001)

Innate sensors for nucleic acids and lupus pathogenesis
por: Theofilopoulos, AN, et al.
Publicado: (2012)

Cytokine profiles of lupus patients with or without nephritis
por: Rovin, BH, et al.
Publicado: (2012)

Prevalence of angina in patients with systemic lupus erythematosus
por: Ishimori, ML, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q5ffughlpfm0fl183nhu6a20ss